← Back to Search

Behavioral Intervention

Video education + adherence contract for Kidney Transplant (VECTOR Trial)

N/A

Recruiting

Research Sponsored by University of Saskatchewan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up study end (12 months after enrolment)

Awards & highlights

VECTOR Trial Summary

This trial will test whether an electronic video intervention and behavioral contract can help kidney transplant patients stick to their medication regimens.

Eligible Conditions

Kidney Transplant
Medication Adherence

VECTOR Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months and 12 months after enrolment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months and 12 months after enrolment

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months and 12 months after enrolment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Difference in adherence to immunosuppressant medications between intervention and control (immunosuppressant blood levels)

Difference in adherence to immunosuppressant medications between intervention and control (self-report)

Secondary outcome measures

Cost of administering the intervention

Days in hospital

Difference in adherence to transplant appointments between intervention and control

+6 more

VECTOR Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Video education + adherence contractExperimental Treatment1 Intervention

electronically delivered video education (at transplant discharge) + electronic adherence contract (1 month after enrolment)

Group II: Standard educationActive Control1 Intervention

standard of care education provided at each transplant center (control emails will be provided at intervention time points)

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of SaskatchewanLead Sponsor

251 Previous Clinical Trials

154,210 Total Patients Enrolled

Saskatchewan Health Authority - Regina AreaOTHER

27 Previous Clinical Trials

5,318 Total Patients Enrolled

Southern Alberta Transplant ProgramUNKNOWN

1 Previous Clinical Trials

162 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the aggregate amount of participants in this clinical experiment?

"To complete the trial, 200 qualified individuals will need to participate. This includes patients from University of Illinois Health Sciences System in Chicago and Southern Alberta Transplant Program based out of Calgary."

Answered by AI

Are there still open positions in this clinical trial for interested participants?

"According to the clinicaltrials.gov registry, this research study is currently enrolling participants. It was initially published on July 1st 2018 and had its latest update occur on May 26th 2022."

Answered by AI

What are the major aims of this research endeavor?

"This trial intends to assess the efficacy of its intervention by tracking adherence and beliefs about medications, along with patient quality-of-life over a period of three months and then again at twelve. To measure these concepts accurately, it will employ two psychometric questionnaires; the Beliefs of Medicine Questionnaire (BMQ) which includes 18 subscales scored on a 5 point Likert scale and the Short Form 12 (SF-12), also rated on a similar scale. The BMQ measures perceptions towards medication while SF-12 is used to determine functional health status relative to an average healthy individual with 50 being midpoint score. Additionally,"

Answered by AI

Recent research and studies

BMJ OpenJournal

Randomised Controlled Trial of a Video Intervention and Behaviour Contract to Improve Medication Adherence After Renal Transplantation: The VECTOR Study Protocol

Mansell, Holly, Nicola Rosaasen, Patricia West-Thielke, Jenny Wichart, Christopher Daley, Rahul Mainra, Ahmed Shoker, Juxin Liu, and David Blackburn. 2019. “Randomised Controlled Trial of a Video Intervention and Behaviour Contract to Improve Medication Adherence After Renal Transplantation: The VECTOR Study Protocol”. BMJ Open. BMJ. doi:10.1136/bmjopen-2018-025495.

clinicaltrials.govStudy

Video Education and Behaviour Contract to Optimize Adherence in Renal Transplants

Holly Mansell 2018. "Video Education and Behaviour Contract to Optimize Adherence in Renal Transplants". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03540121.